Pharmaceutical Business review

Angiotech wins FDA approval for smaller Quill SRS PDO

The Quill Self-Retaining System (SRS) Polydioxanone (PDO) is a longer-lasting absorbable suture, which is typically used for deeper tissue closures. These smaller diameter sizes incorporate a new design for better holding strength and expand the number and scope of procedures that can be done with the Quill SRS product.

William Hunter, president and CEO of Angiotech, said: “We are pleased to receive 510(k) approval for these new smaller diameter sizes. We intend to continue to broaden our Quill SRS product offering to cover multiple procedures for wound closure and tissue approximation.”